Ranibizumab (RG-6321) is a monoclonal antibody that inhibits angiogenesis by inhibiting Vascular endothelial growth factor A. Ranibizumab binds and inhibits vascular endothelial growth factor-a (VEGF-a) to inhibit neoangiogenesis.
Molecular Weight:
48379.16
Purity:
>98%
CAS Number:
[347396-82-1]
Formula:
C2158H3282N562O681S12
Target:
VEGFR/PDGFR
* VAT and and shipping costs not included. Errors and price changes excepted